ENGN financials
enGene Therapeutics (ENGN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ENGN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$123.17M | -$117.30M | 2.29 |
| 2024 | – | – | -$62.30M | -$55.14M | 1.46 |
| 2023 | – | – | -$26.06M | -$104.74M | 151.22 |
| 2022 | – | – | -$19.43M | -$29.02M | 44.30 |